SynthesisEuropean journal of clinical pharmacology2013

Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials.

Yong-Ying Xiao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.